Novel lipid formulations for nucleic acid delivery
作者： Lloyd Jeffs , Lorne Palmer , Kieu Lam , Edward Yaworski , Ian Maclachlan
DOI:
关键词:
摘要: The present invention provides novel, stable lipid particles comprising one or more active agents therapeutic agents, methods of making the particles, and delivering and/or administering particles. More particularly, nucleic acid-lipid (SNALP) a acid (such as interfering RNA), SNALP, SNALP.
lens.org参考文章(150)
Jennifer Lockridge, Pamela Pavco, Nucleic acid-based modulation of gene expression in the vascular endothelial growth factor pathway ,(2003)
Paul C. Sheldon, Back-pressure responsive, self-reversing, control valve ,(2001)
Carbohydrate Modifications in Antisense Research American Chemical Society. ,(1994) , 10.1021/BK-1994-0580
Robert Joseph Kuchler, Biochemical Methods in Cell Culture and Virology ,(1977)
Ian Maclachlan, Lipid-based formulations ,(2002)
Jin-emon Konishi, Pharmaceutical treatments for cerebral and neuronal diseases ,(1989)
Laughton E. M. Miles, Universal reagent 2-site immunoradiometric assay using labelled anti (IgG) ,(1974)
Heidrun Engler, Susan E. Conroy, Daniel C. Maneval, Nucleic acid delivery ,(2004)
Brian Dr Sproat, Giovanni Dr Paolella, Angus Dr Lamond, Synthetic catalytic oligonucleotide structures ,(1992)
Sandra K. Klimuk, Troy O. Harasym, Jonathan L. Bramson, Sean C. Semple, Barbara Mui, Ljiljiana D. Kojic, Michael J. Hope, Compositions for stimulating cytokine secretion and inducing an immune response ,(2000)